Company / Free Cash Flow per Share
Tyra Biosciences, Inc. Free Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.23
FY2024
5-year range
-$5.24 / -$1.19
FY2020-FY2024
Trend
-3.3%
vs FY2023
Sector context
#109 of 192
Health Care
What the data says
At $-1.23, Tyra Biosciences, Inc.'s free cash flow per share ranks #109 of 192 in the Health Care sector.
Based on SEC 10-K filings.
-1.23 in FY2024.
Remained stable around $-1.23 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 192 in Health CareTop 57% of 192This company -$1.23 Sector average -$19.84
▼
+93.8% above sector average
Key checks
Key Insights
- In FY2024, free cash flow per share decreased 3.3% year-over-year.
- Ranks #109 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2023.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.23 | -3.3% |
| FY2023 | -$1.19 | +1.8% |
| FY2022 | -$1.21 | +31.5% |
| FY2021 | -$1.77 | +66.2% |
| FY2020 | -$5.24 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026